Online Writing Intervention for Major Depressive Disorder
Feasibility, Efficacy, and Perceptions of an Online Writing Intervention in Patients With Major Depressive Disorder: A Multi-methods Study
1 other identifier
interventional
63
1 country
1
Brief Summary
The goal of this trial is to examine the feasibility of administering an online writing intervention to patients diagnosed with Major Depressive Disorder, and whether this intervention impacts symptoms of depression. It also examines the impact of the intervention on symptoms of anxiety, personal functioning, and perceived problem complexity, and how participants experience the intervention. The main questions the trial aims to answer are: Will participants randomized to the online writing intervention complete at least three sessions? Is the writing intervention associated with a reduction in symptoms of depression and anxiety, perceived problem complexity, and/or an improvement in personal functioning? What are participants' perceptions of the online writing intervention, including both positive and negative experiences? Participants will: Complete four sessions of an online writing intervention or no writing intervention over the course of one week Complete questionnaires before and after the intervention, and at a one-month follow-up Complete qualitative interviews probing into their experiences with the intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2022
CompletedFirst Submitted
Initial submission to the registry
November 8, 2024
CompletedFirst Posted
Study publicly available on registry
November 21, 2024
CompletedNovember 21, 2024
October 1, 2024
3.2 years
November 8, 2024
November 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of completing EW
Feasibility is defined as 70% of EW participants completing at least three 20-minute sessions of EW.
Feasibility is determined immediately following the completion of the third writing session, which is at minimum after 3 days or one week, on average.
Depressive symptoms
Severity of depressive symptoms, as assessed via the Patient Health Questionnaire (PHQ-9); values range from 0-27 with higher scores indicating greater symptom severity (or worse outcome).
On the next day after the fourth online writing session for participants assigned to EW or after one week for control participants, and at a one-month follow-up for both groups
Secondary Outcomes (3)
Anxiety symptoms
On the next day after the fourth online writing session for participants assigned to EW or after one week for control participants, and at a one-month follow-up for both groups
Impaired functioning
On the next day after the fourth online writing session for participants assigned to EW or after one week for control participants, and at a one-month follow-up for both groups
Problem Complexity
On the next day after the fourth online writing session for participants assigned to EW or after one week for control participants, and at a one-month follow-up for both groups
Study Arms (2)
Control
NO INTERVENTIONParticipants are not asked to complete the online writing intervention
Expressive writing
EXPERIMENTALParticipants are asked to complete four 20-minute sessions of an online writing task on consecutive days.
Interventions
Participants are asked to complete four 20-minute sessions of a writing task on consecutive days, which is sent to their email address via an online link. Participants are instructed "for the next 20 minutes to please use the provided box to write their very deepest thoughts and feelings about a negative issue or personal problem that they are currently being affected by. In their writing, they are encouraged to let go and explore their emotions and thoughts regarding this issue or problem, and to not worry about spelling or grammar. They are asked to consider setting a timer or have a clock handy to make sure they write for 20 minutes." Instructions are accompanied by a text box, which allows participants to write freely for the allotted time.
Eligibility Criteria
You may qualify if:
- adults aged 18 or older
- assessed by a psychiatrist and received a diagnosis of MDD with or without another co-morbid condition
- access to the internet and an email address
You may not qualify if:
- \- no ability to understand, speak, or write in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Addiction and Mental Health
Toronto, Ontario, M5T1R8, Canada
Related Publications (10)
Gratzer D, Goldbloom D. Making Evidence-Based Psychotherapy More Accessible in Canada. Can J Psychiatry. 2016 Oct;61(10):618-23. doi: 10.1177/0706743716642416. Epub 2016 Apr 5. No abstract available.
PMID: 27310234BACKGROUNDHayes AM, Feldman GC, Beevers CG, Laurenceau JP, Cardaciotto L, Lewis-Smith J. Discontinuities and cognitive changes in an exposure-based cognitive therapy for depression. J Consult Clin Psychol. 2007 Jun;75(3):409-421. doi: 10.1037/0022-006X.75.3.409.
PMID: 17563158BACKGROUNDSbarra DA, Boals A, Mason AE, Larson GM, Mehl MR. Expressive Writing Can Impede Emotional Recovery Following Marital Separation. Clin Psychol Sci. 2013 Mar 18;1(2):120-134. doi: 10.1177/2167702612469801.
PMID: 25606351BACKGROUNDKovac SH, Range LM. Does writing about suicidal thoughts and feelings reduce them? Suicide Life Threat Behav. 2002 Winter;32(4):428-40. doi: 10.1521/suli.32.4.428.22335.
PMID: 12501967BACKGROUNDSloan DM, Marx BP, Epstein EM, Lexington JM. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. Epub 2007 Jan 18.
PMID: 17499082BACKGROUNDGortner EM, Rude SS, Pennebaker JW. Benefits of expressive writing in lowering rumination and depressive symptoms. Behav Ther. 2006 Sep;37(3):292-303. doi: 10.1016/j.beth.2006.01.004. Epub 2006 May 30.
PMID: 16942980BACKGROUNDKrpan KM, Kross E, Berman MG, Deldin PJ, Askren MK, Jonides J. An everyday activity as a treatment for depression: the benefits of expressive writing for people diagnosed with major depressive disorder. J Affect Disord. 2013 Sep 25;150(3):1148-51. doi: 10.1016/j.jad.2013.05.065. Epub 2013 Jun 18.
PMID: 23790815BACKGROUNDFrattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull. 2006 Nov;132(6):823-65. doi: 10.1037/0033-2909.132.6.823.
PMID: 17073523BACKGROUNDChiu M, Lebenbaum M, Cheng J, de Oliveira C, Kurdyak P. The direct healthcare costs associated with psychological distress and major depression: A population-based cohort study in Ontario, Canada. PLoS One. 2017 Sep 5;12(9):e0184268. doi: 10.1371/journal.pone.0184268. eCollection 2017.
PMID: 28873469BACKGROUNDBaikie KA, Geerligs L, Wilhelm K. Expressive writing and positive writing for participants with mood disorders: an online randomized controlled trial. J Affect Disord. 2012 Feb;136(3):310-9. doi: 10.1016/j.jad.2011.11.032. Epub 2011 Dec 30.
PMID: 22209127BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benoit H Mulsant, MD, MS, FRCPC, DLFAPA
Centre for Addiction and Mental Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2024
First Posted
November 21, 2024
Study Start
March 27, 2019
Primary Completion
June 14, 2022
Study Completion
June 14, 2022
Last Updated
November 21, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
IPD for this study cannot be made openly-available, because the investigators do not have ethical approval to share personal identifiable, patient-level data outside of the research study. However, code used to generate results is openly available on the Open Science Framework (OSF).